- Home
- NTRSO vs SVA Comparison
NTRSO vs SVA Comparison
Compare NTRSO & SVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRSO
- SVA
- Stock Information
- Founded
- NTRSO N/A
- SVA N/A
- Country
- NTRSO United States
- SVA
- Employees
- NTRSO 23100
- SVA 3261
- Industry
- NTRSO Major Banks
- SVA
- Sector
- NTRSO Finance
- SVA
- Exchange
- NTRSO Nasdaq
- SVA NYSE
- Market Cap
- NTRSO N/A
- SVA N/A
- IPO Year
- NTRSO N/A
- SVA N/A
- Fundamental
- Price
- NTRSO $21.75
- SVA N/A
- Analyst Decision
- NTRSO
- SVA
- Analyst Count
- NTRSO 0
- SVA 0
- Target Price
- NTRSO N/A
- SVA N/A
- AVG Volume (30 Days)
- NTRSO N/A
- SVA N/A
- Earning Date
- NTRSO N/A
- SVA N/A
- Dividend Yield
- NTRSO N/A
- SVA N/A
- EPS Growth
- NTRSO N/A
- SVA N/A
- EPS
- NTRSO N/A
- SVA N/A
- Revenue
- NTRSO N/A
- SVA N/A
- Revenue This Year
- NTRSO N/A
- SVA N/A
- Revenue Next Year
- NTRSO N/A
- SVA N/A
- P/E Ratio
- NTRSO N/A
- SVA N/A
- Revenue Growth
- NTRSO N/A
- SVA N/A
- 52 Week Low
- NTRSO N/A
- SVA N/A
- 52 Week High
- NTRSO N/A
- SVA N/A
- Technical
- Relative Strength Index (RSI)
- NTRSO 36.55
- SVA N/A
- Support Level
- NTRSO $22.48
- SVA N/A
- Resistance Level
- NTRSO $23.04
- SVA N/A
- Average True Range (ATR)
- NTRSO 0.43
- SVA 0.00
- MACD
- NTRSO -0.11
- SVA -0.41
- Stochastic Oscillator
- NTRSO 6.13
- SVA 0.00
About NTRSO Northern Trust Corporation
Northern Trust is a leading provider of wealth management, asset servicing, asset management, and banking to corporations, institutions, affluent families, and individuals. Founded in Chicago in 1889, Northern Trust has offices in 20 states and Washington, D.C. as well as 23 locations in Canada, Europe, the Middle East, and Asia-Pacific. As of Dec. 31, 2023, Northern Trust had assets under custody or administration of $15.4 trillion and assets under management of $1.4 trillion.
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.